Serum legacy and emerging PFAS and lipid biomarkers in patients with chronic coronary syndrome: a cross-sectional human biomonitoring study.
Effect estimates were similar in robust regression and after excluding influential observations, but were attenuated after excluding the highest 5% of exposure values, and should not be interpreted as indicating a favorable lipid effect and require confirmation in larger prospective studies.